Use of the co-grinding method to enhance the dissolution behavior of a poorly water-soluble drug: Generation of solvent-free drug-polymer solid dispersions

Chemical and Pharmaceutical Bulletin

Volumn 60, Issue 7, 2012, Pages 837-845

  Yang, Caiqin ^a   Xu, Xiujuan ^a   Wang, Jing ^a   An, Zhiqian ^a  

^a HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

Dipfluzine; Poloxamer188; Polyvinylpyrrolidone K30; Powder solid co grinding; Solid dispersion; Thermodynamic

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; DIPFLUZINE; POLOXAMER; POVIDONE; UNCLASSIFIED DRUG;

ARTICLE; CRYSTAL; DIFFERENTIAL SCANNING CALORIMETRY; DISPERSION; DRUG SOLUBILITY; ENTHALPY; ENTROPY; GRINDING; HYDROGEN BOND; INFRARED SPECTROSCOPY; PARTICLE SIZE; PHYSICAL CHEMISTRY; SCANNING ELECTRON MICROSCOPY; SOLVENT FREE SOLID DISPERSION; TEMPERATURE; THERMAL ANALYSIS; THERMODYNAMICS; X RAY DIFFRACTION;

EID: 84863545483     PISSN: 00092363     EISSN: 13475223     Source Type: Journal    
DOI: 10.1248/cpb.c12-00034     Document Type: Article

References (24)

1. Chiou W. L., Riegelman S., J. Pharm. Sci., 60, 1281-1302 (1971).
2. Hirasawa N., Ishise S., Miyata H., Danjo K., Chem. Pharm. Bull., 52, 244-247 (2004).
3. Boghra R. J., Kothawade P. C., Belgamwar V. S., Nerkar P. P., Tekade A. R., Surana S. J., Chem. Pharm. Bull., 59, 438-441 (2011).
4. Craig D. Q. M., Int. J. Pharm., 231, 131-144 (2002).
5. Taylor L. S., Zografi G., Pharm. Res., 14, 1691-1698 (1997).
6. Karavas E., Georgarakis M., Docoslis A., Bikiaris D., Int. J. Pharm., 340, 76-83 (2007).
7. Yamashita K., Nakate T., Okimoto K., Ohike A., Tokunaga Y., Ibuki R., Higaki K., Kimura T., Int. J. Pharm., 267, 79-91 (2003).
8. Zhang X. W., Sun N. Y., Wu B. J., Lu Y., Guan T. Z., Wu W., Powder Technol., 182, 480-485 (2008).
9. Sun N. Y., Wei X. L., Wu B. J., Chen J., Lu Y., Wu W., Powder Technol., 182, 72-80 (2008).
10. Moneghini M., Bellich B., Baxa P., Princivalle F., Int. J. Pharm., 361, 125-130 (2008).
11. Moneghini M., Carcano A., Zingone G., Perissutti B., Int. J. Pharm., 175, 177-183 (1998).
12. Watanabe T., Hasegawa S., Wakiyama N., Kusai A., Senna M., Int. J. Pharm., 250, 283-286 (2003).
13. Watanabe T., Ohno I., Wakiyama N., Kusai A., Senna M., Int. J. Pharm., 241, 103-111 (2002).
14. Kakran M., Sahoo N.G., Li L., Colloids Surf. B, 88, 121-130 (2011).
15. Ali W., Williams A. C., Rawlinson C. F., Int. J. Pharm., 391, 162-168 (2010).
16. Wang X., de Armas H. N., Blaton N., Michoel A., Van den Mooter G., Int. J. Pharm., 345, 95-100 (2007).
17. Miao Q. F., Su S. W., Zhang W., Guo M. F., Li L. F., Meng J., Zhang Y. J., Chin. J. Pharmacol. Toxicol., 20, 448-454 (2006).
18. Hu D. D., Miao D. Z., Pei Y. Y., Fudan Univ. J. Med. Sci., 29, 492-494 (2002).
19. Al-Hamidi H., Edwards A. A., Mohammad M. A., Nokhodchi A., Colloids Surf. B, 76, 170-178 (2010).
20. Cirri M., Mura P., Rabasco A. M., Ginés J. M., Moyano J. R., Gònzalez-Rodrìguez M. L., Drug Dev. Ind. Pharm., 30, 65-74 (2004).
21. Gonzalez Novoa G. A., Heinämäki J., Mirza S., Antikainen O., Colarte A. I., Paz A. S., Yliruusi J., Eur. J. Pharm. Biopharm., 59, 343-350 (2005).
22. Rawlinson C. F., Williams A. C., Timmins P., Grimsey I., Int. J. Pharm., 336, 42-48 (2007).
23. Dhirendra K., Lewis S., Udupa N., Atin K., Pak. J. Pharm. Sci., 22, 234-246 (2009).
24. Du Q., Zhao X. R., Zhang X. Y., China Pharmacist, 1, 131-132 (1998).